Clinical Trials Sponsored by Tabba Heart Institute

Total 4764 results

Ottawa Heart Institute Research Corporation

Completed

HYbrid CoronAry Revascularization in DiabeticS (HYCARDS)

Diabetes | Heart Disease

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

PRehabilitiation in Elective Frail and Elderly Cardiac Surgery PaTients (PREFECT)

Coronary Artery Disease | Valvular Heart Disease

Canada
Kansas City Heart Rhythm Institute

Completed

Safety and Efficacy of Left Atrial Appendage Occlusion Devices

Atrial Fibrillation

United States
Ottawa Heart Institute Research Corporation

Completed

Femoral Versus Radial Access for Primary PCI (SAFARI-STEMI)

Myocardial Infarction | STEMI

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX (Closure)

Heart Diseases | Cardiac Surgery | Sternal Injury

Canada
Baker Heart and Diabetes Institute

Withdrawn

Renal Denervation for Uncontrolled Hypertension (RDNP-2012-02)

Hypertension
Baker Heart and Diabetes Institute

Terminated

Renal Denervation for Resistant Hypertension (RDNP-2012-01)

Hypertension

Australia
Baker Heart and Diabetes Institute

Completed

Polycystic Ovary Syndrome - Improving Outcomes

Polycystic Ovary Syndrome

Australia
Ottawa Heart Institute Research Corporation

Completed

Reference Population for Speckle Tracking Imaging (STE Normal)

Left Ventricular Function

Canada
Ottawa Heart Institute Research Corporation

Completed

Study to Monitor the Effects of Androgen Suppression Treatment on the Heart (AST)

Prostate Cancer

Canada
Ottawa Heart Institute Research Corporation

Completed

Autonomic Innervation and MIBG Imaging (MIBG-AF)

Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Completed

A Study of Caffeine on Cardiac Arrhythmias (CACOA-HEART)

Atrial Fibrillation | Supraventricular Tachycardia (SVT)

Canada
Ottawa Heart Institute Research Corporation

Completed

Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not?

Acute Coronary Syndrome

Canada
InCor Heart Institute
Johnson & Johnson

Unknown

Renal Denervation in Patients With Heart Failure Secondary to Chagas Disease

Heart Failure | Chagas Cardiomyopathy | Chagas Disease | Heart Failure, Systolic

Brazil
Baker Heart and Diabetes Institute

Unknown

Study of the Effect of Moxonidine and Diet on Sympathetic Functions in Young Adults With Obesity

Obesity | Overweight

Australia
Baker Heart and Diabetes Institute

Unknown

The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension

Hypertension | Abdominal Obesity

Australia
Ottawa Heart Institute Research Corporation

Completed

Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT)

Acute Coronary Syndrome | Unstable Angina | Non-ST-Elevation Myocardial Infarction

Canada
Arizona Heart Institute
Volcano Corporation

Completed

CAPITAL: Carotid Artery Plaque Intravascular Ultrasound Evaluation

Carotid Artery Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)
Pediatric Heart Network

Completed

Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network (ISV)

Heart Defects, Congenital | Heart Failure, Congestive

United States, Canada
Cairo University
National Heart Institute, Egypt

Not yet recruiting

Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume Overload

Edema | Acute Decompensated Heart Failure | Volume Overload

Egypt
Biozeus Biopharmaceutical S.A.
InCor Heart Institute

Terminated

Efficacy and Safety Evaluation of BZ371B in ARDS Patients

Pulmonary Disease | ARDS | ARDS, Human

Brazil
Montreal Heart Institute
Canadian Cardiovascular Society

Withdrawn

Bromocriptine in the Treatment of Peripartum Cardiomyopathy (BRO-HF)

Peripartum Cardiomyopathy

Canada
Minneapolis Heart Institute Foundation
Regeneron Pharmaceuticals

Terminated

The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial (ASAP-SVG)

Saphenous Vein Graft Atherosclerosis

United States
Cairo University
National Heart Institute, Egypt

Completed

Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI

NSTEMI
Montreal Heart Institute
Université de Montréal

Completed

Feasibility Trial to Maintain Normal Cerebral Oxygen Saturation in High-Risk Cardiac Surgery (Tête-à-coeur)

Cerebral Hypoxia

Canada
Heart and Vascular Outcomes Research Institute

Unknown

Venous Thrombectomy/Thrombolysis Outcome Registry (VETTOR)

Post Thrombotic Syndrome | Deep Venous Thrombosis

United States
Heart and Vascular Outcomes Research Institute

Unknown

Using a Novel Algorithm to Improve the Retrieval Rate of Inferior Vena Cava Filters (iRetrieve Study) (iRetrieve)

Venous Thromboembolism, | Pulmonary Embolism, | Deep Vein Thrombosis,
Tallikut Pharmaceuticals, Inc.
Montreal Heart Institute

Completed

Study Effect of VIA-2291 on Vascular Inflammation

Coronary Artery Disease

Canada, United States
Texas Heart Institute
POM Wonderful LLC

Completed

Pomegranate Products for Prevention of Common Cold

Cough | Fever | Influenza | Headache | Common Cold

United States
Kansas City Heart Rhythm Research Foundation
Kansas City Heart Rhythm Institute

Not yet recruiting

Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry (MAVERIC)

Myocarditis | Ventricular Tachycardia (VT) | Premature Ventricular Contractions

United States
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Evaluation of a Web-based Intervention to Promote Physical Activity in Patients With Heart Disease.

Coronary Artery Disease (CAD)

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation (STEP)

Smoking Cessation

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension (RVMET)

Pulmonary Arterial Hypertension

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling (RW)

Smoking Cessation | Psychiatric Illness

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease (IVR)

Coronary Artery Disease

Canada
Kansas City Heart Rhythm Research Foundation
Kansas City Heart Rhythm Institute

Not yet recruiting

Impact of Steerable Delivery Sheaths on Successful Closure of LA A With AMULET

Stroke | Atrial Fibrillation

United States
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Canada

Recruiting

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (COAST-AF RCT)

Atrial Fibrillation

Canada
Kansas City Heart Rhythm Institute
Kansas City Heart Rhythm Research Foundation

Completed

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation (STROKE-VT)

Stroke | Ventricular Tachycardia | Premature Ventricular Contraction

United States, India
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

The Efficacy and Economics of Exercise Maintenance Post-Cardiac Rehabilitation (ECOPCR)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

A Study of the Effect of Blinding in a Trial of Blood Filtration During Heart Surgery

Heart Diseases

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Endothelial Modulation for Angiogenic Therapy

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

The Efficacy and Cost-Effectiveness of Behavioral Counseling for Exercise in Men and Women Following Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI)

Myocardial Infarction | Coronary Arteriosclerosis

Canada
University of Montana
Providence Heart Institute

Not yet recruiting

Developing and Evaluating an Indoor Air Pollution Intervention Among Cardiovascular Patients: the AIRWISE Study

Cardiovascular Diseases | Coronary Heart Disease | Environmental Exposure
Mayo Clinic
Miami Heart Research Institute

Recruiting

Cancer Survivor Cardiomyopathy Detection (CASCADE)

Cardiovascular Diseases | Cancer

United States
Mayo Clinic
Florida Heart Research Institute

Recruiting

Exercise Training to Improve Cardiopulmonary Hemodynamics in Heart Failure Patients

Heart Failure | Pulmonary Hypertension

United States
The George Institute
World Heart Federation

Not yet recruiting

Essential Acute Stroke Care in Low Resource Settings: a Pilot studY (EASY)

Acute Stroke

Nigeria, Peru
Optina Diagnostics Inc.
Montreal Heart Institute

Completed

Optina Eye to Heart Connection

Coronary Artery Disease

Canada
Montreal Heart Institute
Ingenew Pharmaceuticals Inc.

Completed

Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN) (Hesperidin)

Pain | Confusion | Covid19 | Nausea | Vomiting | Cough | Muscle Weakness | Fever | Headache | Anosmia | Sore Throat | Shortness of Breath | Pain, Joint | Pain, Chest | Irritable Mood | Pain, Abdominal | Pain, Muscle

Canada
Ultromics Ltd
Mazankowski Alberta Heart Institute

Enrolling by invitation

Mazankowski Alberta Heart Institute (MAHI) EchoGo Discovery 1 Protocol

Cancer | Cardiotoxicity

Canada
Sakakibara Heart Institute
CellBank of Japan

Unknown

Japanese OMI Treatment With Kit-positive Cells for Enhanced Regeneration (JOKER)

Chronic Heart Failure | Old Myocardial Infarction

Japan

Clinical Trials Sponsored by Tabba Heart Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations